BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  CVS Health Reports Second Quarter 2018 Results

  Second Quarter Year-over-Year Highlights

  August 8, 2018

   · 

  90 min read
• Business

  uniQure Announces Second Quarter 2018 Financial Results and Highlights Company Progress

  Patient Enrollment Underway in Global Phase III HOPE-B Pivotal Study of AMT-061

  August 8, 2018

   · 

  12 min read
• Deals

  TOT BIOPHARM raises US$102 million in Series B Financing Round

  TOT BIOPHARM’s high-end oncology drug technology platform garners great attention

  August 8, 2018

   · 

  5 min read
• Business

  ProQR Announces Financial Results for the Second Quarter of 2018

  Initiated WINGS, the first clinical trial to evaluate the safety and efficacy of QR-313 in patients that have recessive dystrophic epidermolysis bullosa (RDEB) due to mutations in exon 73 of the COL7A1 gene

  August 8, 2018

   · 

  12 min read
• Business

  Paragon Bioservices Announces Two Key Leadership Promotions

  Paragon Bioservices announces two key leadership promotions.

  August 8, 2018

   · 

  3 min read
• Business

  Endo Reports Second-Quarter 2018 Financial Results

  Second-quarter 2018 revenues of $715 million compared to second-quarter 2017 revenues of $876 million

  August 8, 2018

   · 

  105 min read
• Business

  Charles River Laboratories Announces Second-Quarter 2018 Results from Continuing Operations

  Second-Quarter Revenue of $585.3 Million

  August 8, 2018

   · 

  26 min read
• Business

  Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases

  Ambys also announced today a strategic partnership with Takeda bringing total committed funding at launch to $140 million.

  August 8, 2018

   · 

  4 min read
• Business

  Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases

  Partnership to support the advancement of the Ambys platform and pipeline.

  August 8, 2018

   · 

  5 min read
• Augmedics Begins First-in-Human Clinical Trial of xvision-spine (XVS) Augmented-Reality Surgical Navigation System

  The open label, prospective, single arm, multi-center study will evaluate the safety, performance, accuracy and usability of XVS during spine fusion procedures involving pedicle screw placement.

  August 8, 2018

   · 

  3 min read